心房中隔欠損症の世界市場レポート 2025年

心房中隔欠損症市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR（複合年間成長率）7.7％で60億3,000万米ドルに成長します。予測期間の成長は、術前・術後ケアにおける遠隔医療の利用拡大、遺伝子・表現型データに基づく個別化治療計画の成長、新興市場を中心とした世界のヘルスケア支出の継続的増加、高齢者人口の増加による先天性心疾患の晩年診断率の向上、医療機器規制の国際的調和による世界市場への浸透、先天性心疾患の早期発見・早期治療をターゲットとした国内外での保健プログラムの実施などに起因しています。予測期間における主な動向としては、新しい低侵襲ASD閉鎖デバイスの開発、診断の改善と個別化された治療計画のためのAIと機械学習の利用、デバイス製造のための生分解性および生体吸収性材料の導入、ASD処置中のリアルタイムモニタリングと意思決定支援のためのAI駆動ツール、患者の回復を追跡し合併症を早期に発見するための遠隔モニタリング技術の導入などが挙げられます。

心房中隔欠損症市場は、先天性心疾患（CHD）の有病率の上昇により成長が見込まれています。これらの欠陥は、生まれつき存在する心臓の構造異常です。心房中隔欠損症の治療は、心臓の部屋間の異常な血流を修正し、心臓機能を改善し、関連する合併症を減少させることにより、CHDを管理する上で極めて重要です。例えば、2024年6月にオーストラリア保健福祉研究所が発表したデータによると、オーストラリアでは小児と成人を含めて約6万5,000人が先天性心疾患を抱えて生活していることが明らかになりました。先天性心疾患に関連した入院は2020-21年に約5,900件を占め、1歳未満の乳児の死亡は79件で、乳児死亡全体の7.8％を占めています。このデータは、心房中隔欠損症市場の成長の原動力を裏付けています。

動脈中隔欠損市場の主なプレーヤーは、先進的なデバイスの開発と承認の取得に注力し、その利用可能性と用途を拡大しています。デバイスの承認は、特定の市場や目的でデバイスを製造、販売、使用する前に、規制機関から正式な認可や認証を得るために不可欠です。例えば、2024年3月、Occlutech GmbHは心房中隔欠損症（ASD）治療用のOcclutech ASD OccluderとOcclutech Pistol PusherがFDAから承認されたと発表しました。この画期的な承認により、Occlutech社はB. Braun Interventional Systems社との独占的なパートナーシップを通じて、米国での製品化が可能となりました。自己拡張型ニチノール製デバイスであるオクルーテックASDオクルーダーは、欠陥が確認された患者に生涯にわたるソリューションを提供し、世界的にヘルスケアを向上させます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界心房中隔欠損症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の心房中隔欠損症市場：成長率分析
• 世界の心房中隔欠損症市場の実績：規模と成長, 2019-2024
• 世界の心房中隔欠損症市場の予測：規模と成長, 2024-2029, 2034F
• 世界心房中隔欠損症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の心房中隔欠損症市場治療手順別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外科的閉鎖
• 経カテーテル閉鎖術
• ハイブリッド手術
• 薬物療法
• 世界の心房中隔欠損症市場診断別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 胸部X線検査
• 心電図
• 心臓カテーテル検査
• 経食道心エコー検査
• パルスオキシメトリー
• 世界の心房中隔欠損症市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医療機器
• 医薬品
• 世界の心房中隔欠損症市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児科
• 成人用
• 世界の心房中隔欠損症市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• 心臓クリニック
• その他のエンドユーザー
• 世界の心房中隔欠損症市場、手術閉鎖の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 開胸手術（従来の外科的閉鎖）
• 低侵襲手術による閉鎖
• ASD閉鎖用パッチ（心膜、合成）
• 世界の心房中隔欠損症市場経カテーテル閉鎖術のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• デバイスベースの閉鎖（アムプラッツァー隔壁閉鎖器）
• 経カテーテルプラグ閉鎖技術
• 成人および小児患者に対するカテーテルを用いたASD修復
• 世界の心房中隔欠損症市場ハイブリッド手術の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外科手術と経カテーテル技術の組み合わせ
• 低侵襲ハイブリッド手術
• 複雑または大型のASD向けのハイブリッドクロージャ
• 世界の心房中隔欠損症市場薬物療法の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗凝固療法（脳卒中予防）
• 利尿薬（症状管理用）
• 降圧薬（関連疾患の管理用）
• 他の医薬品の適応外使用

第7章 地域別・国別分析

• 世界の心房中隔欠損症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の心房中隔欠損症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 心房中隔欠損症市場：競合情勢
• 心房中隔欠損症市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Edwards Lifesciences Corporation
• W. L. Gore & Associates Inc.
• St. Jude Medical LLC
• Cook Medical
• Lepu Medical Technology Co. Ltd.
• MicroPort Scientific Corporation
• Lifetech Scientific Corporation
• Venus Medtech Hangzhou Inc
• Occlutech Holding AG
• Coherex Medical
• Osypka AG
• Arjo AB
• Heart Medical Europe BV
• AtriCure Inc.
• Asklepion Pharmaceuticals LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 心房中隔欠損症市場2029：新たな機会を提供する国
• 心房中隔欠損症市場2029：新たな機会を提供するセグメント
• 心房中隔欠損症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

An atrial septal defect (ASD) is a congenital heart defect characterized by an abnormal opening in the septum, the wall separating the heart's two upper chambers (atria). This opening allows oxygen-rich blood from the left atrium to mix with oxygen-poor blood in the right atrium, leading to increased blood flow to the lungs and potential complications such as pulmonary hypertension and heart failure over time.

The main treatment options for atrial septal defects include surgical closure, transcatheter closure, hybrid procedures, and medication therapy. Surgical closure involves repairing or sealing the abnormal opening through surgical intervention. Diagnostic techniques used for ASD include chest x-rays, electrocardiograms, cardiac catheterization, transesophageal echocardiography, and pulse oximetry. These diagnostics are facilitated by medical devices and pharmaceutical products and are utilized in pediatric and adult patients across various healthcare settings, including hospitals, ambulatory surgical centers, cardiac clinics, and others.

The arterial septal defect research report is one of a series of new reports from The Business Research Company that provides arterial septal defect market statistics, including the arterial septal defect industry's global market size, regional shares, competitors with an arterial septal defect market share, detailed arterial septal defect market segments, market trends and opportunities, and any further data you may need to thrive in the arterial septal defect industry. This arterial septal defect market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The atrial septal defect market size has grown strongly in recent years. It will grow from $4.14 billion in 2024 to $4.47 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rise in number of congenital heart disease cases, increased funding for research and development of ASD treatments, high awareness about congenital heart defects among parents and healthcare providers, higher rates of pediatric surgeries, approval of new ASD closure devices and therapies by regulatory bodies like the FDA, expansion of healthcare facilities.

The atrial septal defect market size is expected to see strong growth in the next few years. It will grow to $6.03 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increased use of telemedicine for pre and post-operative care, growth in personalized treatment plans based on genetic and phenotypic data, continued increase in global healthcare spending, particularly in emerging markets, growing elderly population leading to a higher incidence of congenital heart defects being diagnosed later in life international harmonization of medical device regulations improving global market penetration, implementation of national and international health programs targeting early detection and treatment of congenital heart diseases. Major trends in the forecast period include development of new, minimally invasive ASD closure devices, the use of AI and machine learning for improved diagnosis and personalized treatment planning, introduction of biodegradable and bioresorbable materials for device manufacturing, AI-driven tools for real-time monitoring and decision support during ASD procedures, adoption of remote monitoring technologies to track patient recovery and detect complications early.

The atrial septal defect market is anticipated to grow due to the rising prevalence of congenital heart defects (CHD). These defects are structural abnormalities in the heart that exist from birth. Treating atrial septal defects is crucial for managing CHD by correcting abnormal blood flow between the heart's chambers, improving heart function, and reducing associated complications. For example, data from the Australian Institute of Health and Welfare in June 2024 revealed that around 65,000 individuals in Australia, including children and adults, live with congenital heart disease. Hospitalizations related to congenital heart disease accounted for about 5,900 cases in the 2020-21 period, with 79 deaths occurring in infants under one year old, representing 7.8% of all infant deaths. This data underscores the driving force behind the atrial septal defect market's growth.

Key players in the arterial septal defect market are focusing on developing advanced devices and obtaining approvals to expand their availability and applications. Device approval is essential for gaining official authorization or certification from regulatory bodies before manufacturing, selling, or using a device in specific markets or purposes. For instance, in March 2024, Occlutech GmbH announced the FDA's approval of their Occlutech ASD Occluder and Occlutech Pistol Pusher for treating atrial septal defects (ASD). This milestone approval allows Occlutech to commercialize their devices in the US through an exclusive partnership with B. Braun Interventional Systems. The Occlutech ASD Occluder, a self-expanding nitinol device, offers a lifelong solution for patients with confirmed defects, enhancing healthcare globally.

In February 2022, Boston Scientific Corporation acquired Baylis Medical Company Inc. for $1.75 billion. This acquisition expands Boston Scientific's product portfolios in electrophysiology and structural heart interventions with Baylis Medical's transseptal platforms, guidewires, and left heart access tools, including the VersaCross RF Wire designed for creating atrial septal defects.

Major companies operating in the atrial septal defect market are Abbott Laboratories, Medtronic plc, Siemens Healthineers, Boston Scientific Corporation, Philips Healthcare, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., St. Jude Medical LLC, Cook Medical, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Lifetech Scientific Corporation, Venus Medtech Hangzhou Inc, Occlutech Holding AG, Coherex Medical, Osypka AG, Arjo AB, Heart Medical Europe BV, AtriCure Inc., Asklepion Pharmaceuticals LLC

North America was the largest region in the atrial septal defect market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial septal defect market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the atrial septal defect market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The atrial septal defect (ASD) market consists of revenues earned by entities by provide services such as diagnosis and monitoring, medication management, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial septal defect (ASD) market also includes sales of septal occluder devices, cardiac MRI systems, and anticoagulant medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Atrial Septal Defect Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on atrial septal defect market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for atrial septal defect ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The atrial septal defect market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Procedure: Surgical Closure; Transcatheter Closure; Hybrid Procedures; Medication Therapy
• 2) By Diagnosis: Chest X-Ray; Electrocardiogram; Cardiac Catheterization; Transesophageal Echocardiography; Pulse Oximetry
• 3) By Product Type: Medical Devices; Pharmaceutical Products
• 4) By Age Group: Pediatric; Adult
• 5) By End-User: Hospitals; Ambulatory Surgical Centers; Cardiac Clinics; Other End-Users
• Subsegments:
• 1) By Surgical Closure: Open Heart Surgery (Traditional Surgical Closure); Minimally Invasive Surgical Closure; Patches (Pericardial, Synthetic) For Asd Closure
• 2) By Transcatheter Closure: Device-Based Closure (Amplatzer Septal Occluder); Transcatheter Plug Closure Techniques; Catheter-Based Asd Repair For Adult And Pediatric Patients
• 3) By Hybrid Procedures: Combination Of Surgical And Transcatheter Techniques; Minimally Invasive Hybrid Procedures; Hybrid Closure For Complex Or Large Asds
• 4) By Medication Therapy: Anticoagulant Therapy (To Prevent Stroke); Diuretics (For Managing Symptoms); Antihypertensive Drugs (For Managing Associated Conditions); Off-Label Use Of Other Medications
• Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers; Boston Scientific Corporation; Philips Healthcare
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Atrial Septal Defect Market Characteristics

3. Atrial Septal Defect Market Trends And Strategies

4. Atrial Septal Defect Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Atrial Septal Defect Growth Analysis And Strategic Analysis Framework

• 5.1. Global Atrial Septal Defect PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Atrial Septal Defect Market Growth Rate Analysis
• 5.4. Global Atrial Septal Defect Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Atrial Septal Defect Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Atrial Septal Defect Total Addressable Market (TAM)

6. Atrial Septal Defect Market Segmentation

• 6.1. Global Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Closure
• Transcatheter Closure
• Hybrid Procedures
• Medication Therapy
• 6.2. Global Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chest X-Ray
• Electrocardiogram
• Cardiac Catheterization
• Transesophageal Echocardiography
• Pulse Oximetry
• 6.3. Global Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Devices
• Pharmaceutical Products
• 6.4. Global Atrial Septal Defect Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric
• Adult
• 6.5. Global Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Clinics
• Other End-Users
• 6.6. Global Atrial Septal Defect Market, Sub-Segmentation Of Surgical Closure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Open Heart Surgery (Traditional Surgical Closure)
• Minimally Invasive Surgical Closure
• Patches (Pericardial, Synthetic) For Asd Closure
• 6.7. Global Atrial Septal Defect Market, Sub-Segmentation Of Transcatheter Closure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Device-Based Closure (Amplatzer Septal Occluder)
• Transcatheter Plug Closure Techniques
• Catheter-Based Asd Repair For Adult And Pediatric Patients
• 6.8. Global Atrial Septal Defect Market, Sub-Segmentation Of Hybrid Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Combination Of Surgical And Transcatheter Techniques
• Minimally Invasive Hybrid Procedures
• Hybrid Closure For Complex Or Large Asds
• 6.9. Global Atrial Septal Defect Market, Sub-Segmentation Of Medication Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anticoagulant Therapy (To Prevent Stroke)
• Diuretics (For Managing Symptoms)
• Antihypertensive Drugs (For Managing Associated Conditions)
• Off-Label Use Of Other Medications

7. Atrial Septal Defect Market Regional And Country Analysis

• 7.1. Global Atrial Septal Defect Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Atrial Septal Defect Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Atrial Septal Defect Market

• 8.1. Asia-Pacific Atrial Septal Defect Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Atrial Septal Defect Market

• 9.1. China Atrial Septal Defect Market Overview
• 9.2. China Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Atrial Septal Defect Market

• 10.1. India Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Atrial Septal Defect Market

• 11.1. Japan Atrial Septal Defect Market Overview
• 11.2. Japan Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Atrial Septal Defect Market

• 12.1. Australia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Atrial Septal Defect Market

• 13.1. Indonesia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Atrial Septal Defect Market

• 14.1. South Korea Atrial Septal Defect Market Overview
• 14.2. South Korea Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Atrial Septal Defect Market

• 15.1. Western Europe Atrial Septal Defect Market Overview
• 15.2. Western Europe Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Atrial Septal Defect Market

• 16.1. UK Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Atrial Septal Defect Market

• 17.1. Germany Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Atrial Septal Defect Market

• 18.1. France Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Atrial Septal Defect Market

• 19.1. Italy Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Atrial Septal Defect Market

• 20.1. Spain Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Atrial Septal Defect Market

• 21.1. Eastern Europe Atrial Septal Defect Market Overview
• 21.2. Eastern Europe Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Atrial Septal Defect Market

• 22.1. Russia Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Atrial Septal Defect Market

• 23.1. North America Atrial Septal Defect Market Overview
• 23.2. North America Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Atrial Septal Defect Market

• 24.1. USA Atrial Septal Defect Market Overview
• 24.2. USA Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Atrial Septal Defect Market

• 25.1. Canada Atrial Septal Defect Market Overview
• 25.2. Canada Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Atrial Septal Defect Market

• 26.1. South America Atrial Septal Defect Market Overview
• 26.2. South America Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Atrial Septal Defect Market

• 27.1. Brazil Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Atrial Septal Defect Market

• 28.1. Middle East Atrial Septal Defect Market Overview
• 28.2. Middle East Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Atrial Septal Defect Market

• 29.1. Africa Atrial Septal Defect Market Overview
• 29.2. Africa Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Atrial Septal Defect Market Competitive Landscape And Company Profiles

• 30.1. Atrial Septal Defect Market Competitive Landscape
• 30.2. Atrial Septal Defect Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

31. Atrial Septal Defect Market Other Major And Innovative Companies

• 31.1. Edwards Lifesciences Corporation
• 31.2. W. L. Gore & Associates Inc.
• 31.3. St. Jude Medical LLC
• 31.4. Cook Medical
• 31.5. Lepu Medical Technology Co. Ltd.
• 31.6. MicroPort Scientific Corporation
• 31.7. Lifetech Scientific Corporation
• 31.8. Venus Medtech Hangzhou Inc
• 31.9. Occlutech Holding AG
• 31.10. Coherex Medical
• 31.11. Osypka AG
• 31.12. Arjo AB
• 31.13. Heart Medical Europe BV
• 31.14. AtriCure Inc.
• 31.15. Asklepion Pharmaceuticals LLC

32. Global Atrial Septal Defect Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Atrial Septal Defect Market

34. Recent Developments In The Atrial Septal Defect Market

35. Atrial Septal Defect Market High Potential Countries, Segments and Strategies

• 35.1 Atrial Septal Defect Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Atrial Septal Defect Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Atrial Septal Defect Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer